Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Nobel Biocare Has Gotten Its Teeth Kicked In

How unpopular is Swiss dental device company Nobel Biocare (OTCPK:NBHGY)? The stock was down 30% in 2012 and is down 75% over the past three years, but the stock still carries an overwhelming number of "Sell" recommendations. While Nobel has seen some significant negative developments in its core dental implants market, it's still worth asking whether this stock may not carry some value for risk-tolerant deep-value turnaround investors.

Focused On Better Smiles

While Nobel Biocare does offer a wide array of products including prosthetics like crowns and bridges and the NobelProcera CAD/CAM system, the business is very much built around its dental implants. As the name might suggest, dental implants are basically implantable products that are drilled/anchored into...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details